Skip to content

Clinical trials

Phase 3 Myasthenia Gravis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myasthenia Gravis Phase: Phase 3 Country / region: Canada Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20111
20131
20142
20181
20196
20201
20216
20222
20232
20244
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting8
Recruiting5
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Biopharma SRL6
argenx5
Alexion Pharmaceuticals, Inc.4
Hoffmann-La Roche2
University Health Network, Toronto2
Amgen1
Cartesian Therapeutics1
Clinique Neuro-Outaouais1
Immunovant Sciences GmbH1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myasthenia Gravis33
Thymoma1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.